Treatment Resistant Depression (trd) Clinical Trials
2 recruiting trials for Treatment Resistant Depression (trd). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Treatment Resistant Depression (trd) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Riccardo Guglielmo (1), Tianjin Anding Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Esketamine (Intranasal Spray) (drug, 1 trial), followed by transcranial Alternating Current Stimulation (tACS), Sham stimulation.
Track Treatment Resistant Depression (trd) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression
This observational study investigates the use of Esketamine Intranasal Spray in patients with Treatment-Resistant Depression in Real-World Settings. The study aims to evaluate the...
TACS on High-inflammatory and Refractory Depression
This study is a randomized controlled trial with a duration of 12 weeks (4 weeks of intervention + 8 weeks of follow-up). The participants are patients with treatment-resistant...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Treatment Resistant Depression (trd), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Treatment Resistant Depression (trd), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Treatment Resistant Depression (trd), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.